Open Access

Unlocking the potential of baroreflex activation therapy (BAT) for HFrEF patients

Event: ESC Congress 2022
Topic: Heart Failure with Reduced Ejection Fraction (HFrEF)
Session type: Satellite Symposium
Sponsored by Charité Friends & Sponsors Trust
Date: 29 August 2022
Time: 10:15 - 11:00

Congress Session

This content is currently on OPEN ACCESS

Sign in to view the resources

5 presentations in this session

Introduction.

Speaker: Professor S. Anker (Berlin, DE)
Thumbnail

BAT: how does it work?

Speaker: Doctor M. Fudim (Durham, US)
Thumbnail

BAT: what have we learned from clinical trials?

Speaker: Professor W. Abraham (Columbus, US)
Thumbnail

BAT: what has real-world experience taught us?

Speaker: Professor J. Bauersachs (Hannover, DE)
Thumbnail

Panel discussion and conclusion.

Speaker: Professor A. Coats (Coventry, GB)
Speaker: Professor S. Anker (Berlin, DE)
Speaker: Professor J. Bauersachs (Hannover, DE)
Speaker: Professor W. Abraham (Columbus, US)
Thumbnail

8 speakers from this session

Professor Stefan Anker

Charite Universitatsmedizin Berlin, Berlin (Germany)
114 presentations
4 followers

Doctor Marat Fudim

Duke Clinical Research Institute, Durham (United States of America)
6 presentations
1 follower

Professor William Abraham

The Ohio State University, Columbus (United States of America)
39 presentations
2 followers

Professor Johann Bauersachs

Hannover Medical School, Hannover (Germany)
31 presentations
4 followers

Professor Andrew Coats

University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)
96 presentations
14 followers

Professor Stefan Anker

Charite Universitatsmedizin Berlin, Berlin (Germany)
114 presentations
4 followers

Professor Johann Bauersachs

Hannover Medical School, Hannover (Germany)
31 presentations
4 followers

Professor William Abraham

The Ohio State University, Columbus (United States of America)
39 presentations
2 followers

This platform is supported by

logo Novo Nordisk